Asymchem Laboratories (Tianjin) Co., Ltd. (FRA:7K90)

Germany flag Germany · Delayed Price · Currency is EUR
8.45
+0.10 (1.20%)
At close: Dec 4, 2025
40.83%
Market Cap 3.96B
Revenue (ttm) 753.54M
Net Income (ttm) 124.37M
Shares Out n/a
EPS (ttm) 0.34
PE Ratio 31.81
Forward PE 24.03
Dividend 0.13 (1.56%)
Ex-Dividend Date Jun 25, 2025
Volume n/a
Average Volume 3
Open 8.45
Previous Close 8.35
Day's Range 8.45 - 8.45
52-Week Range 4.50 - 12.30
Beta n/a
RSI 43.48
Earnings Date Apr 1, 2026

About FRA:7K90

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing... [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 9,595
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 7K90
Full Company Profile

Financial Performance

In 2024, FRA:7K90's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.